Mainz Biomed B.V. (MYNZ) Ownership

$5.07

north_east
$0.69 (15.75%)
Day's range
$4.44
Day's range
$5.49

Mainz Biomed B.V. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VONTOBEL HOLDING LTD. 10/16/2024 45,000 $11,174   80.00% 0.25%
NORTHERN TRUST CORP 11/13/2024 29,934 $7,454   0.00% 0.17%
STEWARD PARTNERS INVESTMENT ADVISORY, LLC 11/14/2024 29,000 $7,221   100.00% 0.16%
TWO SIGMA SECURITIES, LLC 11/14/2024 23,515 $5,855   100.00% 0.13%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 15,189 $3,782   0.00% 0.09%
JANE STREET GROUP, LLC 11/15/2024 14,559 $3,625   100.00% 0.08%
XTX TOPCO LTD 11/14/2024 11,953 $2,976   5.24% 0.07%
WEALTH QUARTERBACK LLC 11/01/2024 10,000 $2,490   0.00% 0.06%
FMR LLC 11/13/2024 1,850 $461   100.00% 0.01%
CITIGROUP INC 11/12/2024 673 $168   0.00% 0.00%
MORGAN STANLEY 11/14/2024 200 $50   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 11/14/2024 0 $0   -100.00% 0.00%

Mainz Biomed B.V. institutional Ownership - FAQ's

During the previous two years, 13 institutional investors and hedge funds held shares of Mainz Biomed B.V.. The most heavily invested institutionals were:

FMR LLC: 0

TWO SIGMA SECURITIES, LLC: 0

Vontobel Holding Ltd.: 0

GEODE CAPITAL MANAGEMENT, LLC: 0

XTX Topco Ltd: 0

Steward Partners Investment Advisory, LLC: 0

1.03% of Mainz Biomed B.V. stock is owned by institutional investors.

Institutional investors have bought a total of 40,993 shares in the last 24 months. This purchase volume represents approximately $207,835 in transactions.